Nirvana Life Sciences (CSE:NIRV) was based to develop novel therapeutic merchandise derived from psychedelics.
The corporate has focused two merchandise for its first improvement part. One product will deal with transitioning from opioids to non-addictive ache aid therapies and ideally prevents relapse. The second product will present non-addictive ache aid. Nirvana Life Sciences started by buying the mental property (IP) behind these formulations and has since performed its personal analysis to advance them.
It has acquired a Part 56 Exemption from Well being Canada, enabling them to legally conduct its analysis and improvement in Vancouver. Moreover, its new facility can be constructed to Stage 9 Safety Requirements to safeguard its analysis. Pre-clinical analysis for its formulations have already begun. This analysis is being undertaken on the College of Camerino in Italy. This lab was granted particular permission from the Italian authorities to work with psilocybin-based compounds. Stories from these trials are anticipated in Q3 2022.
Firm Highlights
- Nirvana Life Sciences is an progressive analysis and improvement firm targeted on novel formulations for opioid habit and ache administration that use psychedelic compounds.
- The corporate is solely targeted on merchandise, somewhat than wellness retreats or psychotherapy applications like a few of its opponents.
- Nirvana Life Sciences’ first part of improvement is focusing on two merchandise, one to help in opioid habit restoration and the opposite is focusing on non-addictive ache administration.
- IP has been bought from researchers who’ve extensively studied the consequences of psychedelic compounds for medicinal functions
- The corporate is taking each precaution to function legally and shield in opposition to potential felony parts that will goal its amenities
- Pre-clinical analysis started in 2021 and the outcomes are anticipated in Q3 2022 and can decide future developments
- A powerful workforce of medical doctors and visionaries lead the corporate, every bringing their specialty to the corporate to totally develop its merchandise
This Nirvana Life Sciences firm profile is a part of a paid investor schooling marketing campaign.*
